These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 21752642

  • 1. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
    Manvar A, Bavishi A, Radadiya A, Patel J, Vora V, Dodia N, Rawal K, Shah A.
    Bioorg Med Chem Lett; 2011 Aug 15; 21(16):4728-31. PubMed ID: 21752642
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and binary QSAR study of antitubercular quinolylhydrazides.
    Manvar A, Khedkar V, Patel J, Vora V, Dodia N, Patel G, Coutinho E, Shah A.
    Bioorg Med Chem Lett; 2013 Sep 01; 23(17):4896-902. PubMed ID: 23876988
    [Abstract] [Full Text] [Related]

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 01; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 4. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
    Torres E, Moreno E, Ancizu S, Barea C, Galiano S, Aldana I, Monge A, Pérez-Silanes S.
    Bioorg Med Chem Lett; 2011 Jun 15; 21(12):3699-703. PubMed ID: 21570839
    [Abstract] [Full Text] [Related]

  • 5. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M, Husain I, Sharma S, Yadav G, Singh VK, Sharma SK, Shah P, Siddiqi MI, Kumar B, Lal J, Jain GK, Srivastava BS, Srivastava R, Shaw AK.
    Eur J Med Chem; 2011 Jun 15; 46(6):2217-23. PubMed ID: 21440336
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.
    De P, Koumba Yoya G, Constant P, Bedos-Belval F, Duran H, Saffon N, Daffé M, Baltas M.
    J Med Chem; 2011 Mar 10; 54(5):1449-61. PubMed ID: 21309577
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
    Jordão AK, Sathler PC, Ferreira VF, Campos VR, de Souza MC, Castro HC, Lannes A, Lourenco A, Rodrigues CR, Bello ML, Lourenco MC, Carvalho GS, Almeida MC, Cunha AC.
    Bioorg Med Chem; 2011 Sep 15; 19(18):5605-11. PubMed ID: 21840219
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and antimycobacterial activity of N'-[(E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide derivatives.
    Vergara FM, Lima CH, Henriques Md, Candéa AL, Lourenço MC, Ferreira Mde L, Kaiser CR, de Souza MV.
    Eur J Med Chem; 2009 Dec 15; 44(12):4954-9. PubMed ID: 19765866
    [Abstract] [Full Text] [Related]

  • 9. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
    Herzigová P, Klimesová V, Palát K, Kaustová J, Dahse HM, Möllmann U.
    Arch Pharm (Weinheim); 2009 Jul 15; 342(7):394-404. PubMed ID: 19536781
    [Abstract] [Full Text] [Related]

  • 10. A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of new-fangled dispiropyrrolothiazoles as antimycobacterial agents.
    Almansour AI, Ali S, Ali MA, Ismail R, Choon TS, Sellappan V, Elumalai KK, Pandian S.
    Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7418-21. PubMed ID: 23122863
    [Abstract] [Full Text] [Related]

  • 11. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
    Carta A, Palomba M, Paglietti G, Molicotti P, Paglietti B, Cannas S, Zanetti S.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4791-4. PubMed ID: 17604166
    [Abstract] [Full Text] [Related]

  • 12. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
    Indumathi S, Perumal S, Banerjee D, Yogeeswari P, Sriram D.
    Eur J Med Chem; 2009 Dec 01; 44(12):4978-84. PubMed ID: 19781824
    [Abstract] [Full Text] [Related]

  • 13. Antimycobacterial activity: synthesis of novel 3-(substituted phenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
    Ali MA, Ismail R, Choon TS, Pandian S, Hassan Ansari MZ.
    J Enzyme Inhib Med Chem; 2011 Aug 01; 26(4):598-602. PubMed ID: 21714764
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.
    Roy KK, Singh S, Sharma SK, Srivastava R, Chaturvedi V, Saxena AK.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5589-93. PubMed ID: 21783364
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
    Trivedi A, Vaghasiya S, Dholariya B, Dodiya D, Shah V.
    J Enzyme Inhib Med Chem; 2010 Dec 15; 25(6):893-9. PubMed ID: 21054238
    [Abstract] [Full Text] [Related]

  • 16. Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.
    Kamal A, Shetti RV, Azeeza S, Swapna P, Khan MN, Khan IA, Sharma S, Abdullah ST.
    Eur J Med Chem; 2011 Mar 15; 46(3):893-900. PubMed ID: 21272965
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and preliminary in vitro evaluation of antimycobacterial activity of new pyrrolo[1,2-a] quinoxaline-carboxylic acid hydrazide derivatives.
    Guillon J, Reynolds RC, Leger JM, Guie MA, Massip S, Dallemagne P, Jarry C.
    J Enzyme Inhib Med Chem; 2004 Dec 15; 19(6):489-95. PubMed ID: 15662953
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J, Yue J, Wu J, Luo R, Hu Z, Li J, Bai Y, Tang Z, Xian Q, Zhang X, Wang H.
    Pharmacology; 2010 Dec 15; 85(6):365-71. PubMed ID: 20530976
    [Abstract] [Full Text] [Related]

  • 19. Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis.
    Del Olmo E, Molina-Salinas GM, Escarcena R, Alves M, López-Pérez JL, Hernandez-Pando R, Said-Fernández S, Feliciano AS.
    Bioorg Med Chem Lett; 2009 Oct 01; 19(19):5764-8. PubMed ID: 19703769
    [Abstract] [Full Text] [Related]

  • 20. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N, Srivastav NC, Desroches N, Agrawal B, Kunimoto DY, Kumar R.
    J Med Chem; 2010 May 27; 53(10):4130-40. PubMed ID: 20420370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.